CDSCO Panel grants Sanofi's Updated Prescribing Information for FDC Ibuprofen plus Paracetamol Written By Dr. Divya Colin18 Feb 2024 6:00 PM ISTNew Delhi: The drug major Sanofi has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Sanofi Dupixent gets Japenese nod for chronic spontaneous urticaria Written By Ruchika Sharma18 Feb 2024 10:00 AM ISTParis: Sanofi has announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization...
Lupin bags USFDA okay Dronedarone Tablets Written By Ruchika Sharma2 Feb 2024 12:06 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration...
Sanofi Dupixent approved by USFDA for pediatric patients aged 1 to 11 years with eosinophilic esophagitis Written By Ruchika Sharma28 Jan 2024 2:30 PM ISTParis: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of...
Sanofi to acquire Inhibrx Written By Ruchika Sharma26 Jan 2024 10:00 AM ISTParis: Sanofi and Inhibrx, Inc., a publicly traded clinical-stage biopharmaceutical company, have entered into a definitive agreement under which...
Submit Modified Informed Consent Form with details: CDSCO Panel Tells Sanofi om Multiple Sclerosis Drug Tolebrutinib Written By Dr. Divya Colin21 Jan 2024 6:00 PM ISTNew Delhi: Reviewing the Phase III clinical study protocol of Tolebrutinib presented by the drug major Sanofi, the Subject Expert Committee (SEC)...
CDSCO Panel Approves Sanofi's Protocol Amendment proposal for COPD drug Itepekimab Written By Dr. Divya Colin21 Jan 2024 5:00 PM ISTNew Delhi: The Subject Expert Panel (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Sanofi's...
USFDA updates Sanofi Dupixent label for atopic dermatitis Written By Ruchika Sharma18 Jan 2024 3:00 PM ISTParis: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has updated the label for Dupixent (dupilumab) in atopic dermatitis,...
Sanofi names Brian Foard as head of Specialty Care Global Business Unit Ruchika Sharma10 Jan 2024 1:30 PM ISTParis: Brian Foard, a healthcare industry veteran and Sanofi leader in the U.S., has been named Head of the company's Specialty Care Global...
AstraZeneca-Sanofi Beyfortus gets nod for RSV disease prevention in infants in China Written By Ruchika Sharma2 Jan 2024 3:06 PM ISTChina: AstraZeneca and Sanofi's Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in China for the prevention of...
Lupin to buy established products portfolio in Europe, Canada from Sanofi for Rs 91 crore Ruchika Sharma23 Dec 2023 3:47 PM ISTUnder the agreement, Lupin will acquire brands AARANE in Germany and NALCROM in Canada and the Netherlands.
Sanofi India names Himanshu Bakshi as General Manager for Consumer Healthcare Business Roshni Dhar20 Dec 2023 5:51 PM ISTSanofi India Limited (SIL) has announced the appointment of Himanshu Bakshi as General Manager for its Consumer Healthcare (CHC) business, effective...
